nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—KCNJ1—Potassium transport channels—KCNJ10—amyotrophic lateral sclerosis	0.251	0.352	CbGpPWpGaD
Tolbutamide—KCNJ1—appendage—amyotrophic lateral sclerosis	0.0713	0.265	CbGeAlD
Tolbutamide—KCNJ1—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.0387	0.0544	CbGpPWpGaD
Tolbutamide—ABCC8—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.0198	0.0278	CbGpPWpGaD
Tolbutamide—Gliclazide—VEGFA—amyotrophic lateral sclerosis	0.0195	1	CrCbGaD
Tolbutamide—KCNJ11—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.0192	0.027	CbGpPWpGaD
Tolbutamide—KCNJ1—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.0153	0.0215	CbGpPWpGaD
Tolbutamide—ABCC8—brainstem—amyotrophic lateral sclerosis	0.0121	0.045	CbGeAlD
Tolbutamide—KCNJ1—nervous system—amyotrophic lateral sclerosis	0.0114	0.0422	CbGeAlD
Tolbutamide—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.011	0.0155	CbGpPWpGaD
Tolbutamide—KCNJ1—central nervous system—amyotrophic lateral sclerosis	0.011	0.0406	CbGeAlD
Tolbutamide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.0102	0.0144	CbGpPWpGaD
Tolbutamide—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00935	0.0132	CbGpPWpGaD
Tolbutamide—KCNJ1—brain—amyotrophic lateral sclerosis	0.00869	0.0322	CbGeAlD
Tolbutamide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00868	0.0122	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00858	0.0121	CbGpPWpGaD
Tolbutamide—ABCC8—medulla oblongata—amyotrophic lateral sclerosis	0.00846	0.0314	CbGeAlD
Tolbutamide—ABCC8—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.00781	0.011	CbGpPWpGaD
Tolbutamide—KCNJ11—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.00757	0.0106	CbGpPWpGaD
Tolbutamide—ABCC8—spinal cord—amyotrophic lateral sclerosis	0.00754	0.028	CbGeAlD
Tolbutamide—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0071	0.00998	CbGpPWpGaD
Tolbutamide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00699	0.00983	CbGpPWpGaD
Tolbutamide—KCNJ11—nervous system—amyotrophic lateral sclerosis	0.0069	0.0256	CbGeAlD
Tolbutamide—KCNJ1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00667	0.00938	CbGpPWpGaD
Tolbutamide—KCNJ11—central nervous system—amyotrophic lateral sclerosis	0.00664	0.0246	CbGeAlD
Tolbutamide—SLCO2B1—medulla oblongata—amyotrophic lateral sclerosis	0.00662	0.0245	CbGeAlD
Tolbutamide—KCNJ11—cerebellum—amyotrophic lateral sclerosis	0.00649	0.0241	CbGeAlD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00647	0.00911	CbGpPWpGaD
Tolbutamide—ABCC8—nervous system—amyotrophic lateral sclerosis	0.00636	0.0236	CbGeAlD
Tolbutamide—KCNJ1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00615	0.00866	CbGpPWpGaD
Tolbutamide—ABCC8—central nervous system—amyotrophic lateral sclerosis	0.00612	0.0227	CbGeAlD
Tolbutamide—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.00609	0.0226	CbGeAlD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00601	0.00845	CbGpPWpGaD
Tolbutamide—ABCC8—cerebellum—amyotrophic lateral sclerosis	0.00598	0.0222	CbGeAlD
Tolbutamide—KCNJ1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00594	0.00836	CbGpPWpGaD
Tolbutamide—SLCO2B1—spinal cord—amyotrophic lateral sclerosis	0.0059	0.0219	CbGeAlD
Tolbutamide—SLC22A6—brain—amyotrophic lateral sclerosis	0.00558	0.0207	CbGeAlD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00551	0.00774	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00544	0.00765	CbGpPWpGaD
Tolbutamide—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.00543	0.0201	CbGeAlD
Tolbutamide—KCNJ11—brain—amyotrophic lateral sclerosis	0.00527	0.0196	CbGeAlD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00511	0.00719	CbGpPWpGaD
Tolbutamide—SLC15A2—medulla oblongata—amyotrophic lateral sclerosis	0.00506	0.0187	CbGeAlD
Tolbutamide—KCNJ1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00505	0.00711	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00505	0.00711	CbGpPWpGaD
Tolbutamide—SLCO2B1—nervous system—amyotrophic lateral sclerosis	0.00497	0.0184	CbGeAlD
Tolbutamide—ABCC8—brain—amyotrophic lateral sclerosis	0.00486	0.018	CbGeAlD
Tolbutamide—CYP2C18—FOXA1 transcription factor network—SOD1—amyotrophic lateral sclerosis	0.00486	0.00683	CbGpPWpGaD
Tolbutamide—SLCO2B1—central nervous system—amyotrophic lateral sclerosis	0.00479	0.0178	CbGeAlD
Tolbutamide—SLCO2B1—cerebellum—amyotrophic lateral sclerosis	0.00468	0.0174	CbGeAlD
Tolbutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00464	0.00653	CbGpPWpGaD
Tolbutamide—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.00458	0.017	CbGeAlD
Tolbutamide—SLC15A2—spinal cord—amyotrophic lateral sclerosis	0.00451	0.0167	CbGeAlD
Tolbutamide—KCNJ1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0045	0.00634	CbGpPWpGaD
Tolbutamide—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.00441	0.0163	CbGeAlD
Tolbutamide—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.00431	0.016	CbGeAlD
Tolbutamide—SLCO2B1—brain—amyotrophic lateral sclerosis	0.0038	0.0141	CbGeAlD
Tolbutamide—SLC15A2—nervous system—amyotrophic lateral sclerosis	0.0038	0.0141	CbGeAlD
Tolbutamide—SLC15A2—central nervous system—amyotrophic lateral sclerosis	0.00366	0.0136	CbGeAlD
Tolbutamide—SLC15A2—cerebellum—amyotrophic lateral sclerosis	0.00357	0.0133	CbGeAlD
Tolbutamide—CYP2C18—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00356	0.00501	CbGpPWpGaD
Tolbutamide—SLCO1A2—brain—amyotrophic lateral sclerosis	0.0035	0.013	CbGeAlD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00346	0.00486	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00341	0.00479	CbGpPWpGaD
Tolbutamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00332	0.00468	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0033	0.00465	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00314	0.00442	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00305	0.00429	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00304	0.00427	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00295	0.00414	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00294	0.00413	CbGpPWpGaD
Tolbutamide—SLC15A2—brain—amyotrophic lateral sclerosis	0.0029	0.0108	CbGeAlD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00289	0.00407	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00278	0.00391	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00273	0.00383	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00269	0.00379	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00269	0.00378	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00262	0.00369	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00258	0.00363	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00258	0.00363	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00253	0.00357	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0025	0.00352	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0025	0.00352	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00246	0.00346	CbGpPWpGaD
Tolbutamide—CYP2C8—brain—amyotrophic lateral sclerosis	0.00244	0.00906	CbGeAlD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00232	0.00326	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0023	0.00324	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00228	0.00321	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00228	0.00321	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00223	0.00314	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00219	0.00308	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00212	0.00299	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00212	0.00298	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00212	0.00298	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00204	0.00286	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00199	0.0028	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00197	0.00278	CbGpPWpGaD
Tolbutamide—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00186	0.00261	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00186	0.00261	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.0018	0.00254	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00176	0.00247	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00169	0.00238	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00167	0.00235	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00164	0.0023	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00163	0.0023	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00161	0.00226	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00159	0.00224	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00157	0.00221	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00157	0.00221	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00157	0.0022	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00157	0.0022	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00152	0.00214	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00152	0.00214	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00151	0.00213	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00149	0.0021	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00149	0.0021	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00148	0.00208	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00147	0.00207	CbGpPWpGaD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00146	0.00205	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00143	0.00202	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00139	0.00195	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00139	0.00195	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00139	0.00195	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00136	0.00192	CbGpPWpGaD
Tolbutamide—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00133	0.00187	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00133	0.00187	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00133	0.00187	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00132	0.00186	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00129	0.00182	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00127	0.00179	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00125	0.00176	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00125	0.00176	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00125	0.00176	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00124	0.00174	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00122	0.00172	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00122	0.00172	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00121	0.00171	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00121	0.0017	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00116	0.00163	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00116	0.00163	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00114	0.0016	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—DAO—amyotrophic lateral sclerosis	0.00113	0.00159	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00112	0.00157	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00111	0.00157	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—DAO—amyotrophic lateral sclerosis	0.0011	0.00154	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00108	0.00152	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00104	0.00147	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00104	0.00146	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00145	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00103	0.00145	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00103	0.00145	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00102	0.00143	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00101	0.00143	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000975	0.00137	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00097	0.00136	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000964	0.00136	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000945	0.00133	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000931	0.00131	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000928	0.00131	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000923	0.0013	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000916	0.00129	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000916	0.00129	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000912	0.00128	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—DAO—amyotrophic lateral sclerosis	0.000882	0.00124	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000879	0.00124	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000865	0.00122	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000861	0.00121	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000861	0.00121	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000858	0.00121	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000849	0.00119	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000832	0.00117	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000826	0.00116	CbGpPWpGaD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000823	0.00116	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000817	0.00115	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000814	0.00114	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000792	0.00111	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000789	0.00111	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSR—amyotrophic lateral sclerosis	0.000768	0.00108	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000768	0.00108	CbGpPWpGaD
Tolbutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000751	0.00106	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000747	0.00105	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000742	0.00104	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000669	0.000941	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000663	0.000932	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000654	0.00092	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00065	0.000915	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000631	0.000887	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000625	0.000879	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSR—amyotrophic lateral sclerosis	0.000617	0.000868	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000592	0.000832	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000583	0.000821	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000566	0.000797	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000558	0.000785	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000539	0.000759	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000532	0.000748	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000523	0.000735	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000509	0.000715	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000508	0.000714	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000508	0.000714	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000507	0.000713	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000476	0.00067	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000474	0.000666	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000464	0.000653	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000453	0.000638	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000453	0.000638	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000432	0.000608	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000429	0.000604	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000423	0.000595	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000415	0.000583	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000413	0.000581	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000413	0.000581	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000406	0.000571	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000392	0.000551	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000385	0.000542	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000385	0.000542	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000378	0.000532	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000367	0.000517	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000362	0.00051	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000351	0.000494	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00035	0.000492	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000339	0.000477	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00033	0.000465	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	0.000328	0.000461	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000321	0.000452	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000311	0.000438	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000299	0.00042	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000278	0.000391	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000272	0.000383	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000268	0.000377	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—APOE—amyotrophic lateral sclerosis	0.000264	0.000372	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000257	0.000361	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—APOE—amyotrophic lateral sclerosis	0.000256	0.000361	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00025	0.000352	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000248	0.000349	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000234	0.000329	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000231	0.000324	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	0.000229	0.000322	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000226	0.000319	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000212	0.000298	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000211	0.000297	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000209	0.000294	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000209	0.000294	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	0.000206	0.00029	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000192	0.000271	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00019	0.000268	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000188	0.000265	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000181	0.000255	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000176	0.000247	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000174	0.000245	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000172	0.000242	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000172	0.000241	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000157	0.00022	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000141	0.000198	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000132	0.000185	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000119	0.000168	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000118	0.000166	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000113	0.000159	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000107	0.000151	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000104	0.000147	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000101	0.000142	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.3e-05	0.000131	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.22e-05	0.00013	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	8.57e-05	0.000121	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.48e-05	0.000119	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	7.65e-05	0.000108	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	6.97e-05	9.81e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.87e-05	8.26e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.24e-05	7.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.78e-05	6.72e-05	CbGpPWpGaD
